Published in Medical Letter on the CDC and FDA, August 12th, 1996
The acellular pertussis component of the vaccine is produced by the Research Foundation for Microbial Diseases of Osaka University in Japan. It is combined with diphtheria and tetanus toxoids by Connaught Laboratories, Inc., and is sold under the trade name, Tripedia.
The vaccine protects infants against whooping cough while causing fewer side-effects than whole-cell pertussis vaccines now on the market. Currently, U.S. children receive a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.